Non-Serotonergic Anxiolytic and Sleep Medication Options While Continuing Propranolol
For anxiety management without serotonergic effects while continuing propranolol, gabapentin (starting 100-300 mg nightly, titrating to 900-3600 mg daily in divided doses) is your best evidence-based option, and for sleep-specific treatment, use short-intermediate acting benzodiazepine receptor agonists like zolpidem (10 mg at bedtime) or eszopiclone (2-3 mg at bedtime) as first-line agents. 1
Anxiolytic Options (Non-Serotonergic)
First-Line: Gabapentin
- Starting dose: 100-300 mg nightly
- Target dose: 900-3600 mg daily in divided doses (2-3 times daily)
- Titration: Increase by 50-100% every few days; slower for elderly or medically frail
- Key advantage: No serotonergic activity, well-tolerated with propranolol
- Important: Requires dose adjustment for renal insufficiency 2
Alternative: Pregabalin
- Starting dose: 50 mg three times daily
- Target dose: 100 mg three times daily (maximum 600 mg daily in divided doses)
- Advantage: More efficient GI absorption than gabapentin
- Note: Also requires renal dose adjustment 2
Propranolol Continuation
Your current propranolol can remain unchanged—it has documented anxiolytic effects for somatic anxiety symptoms and performance anxiety at doses of 20-40 mg once to three times daily 3. There are no significant interactions between propranolol and gabapentin/pregabalin.
Sleep-Specific Medications
First-Line Options (per AASM Guidelines)
Short-intermediate acting benzodiazepine receptor agonists (BzRAs):
Zolpidem 1
- 10 mg at bedtime (5 mg for elderly/debilitated)
- Primarily for sleep-onset insomnia
- Short to intermediate-acting
Eszopiclone 1
- 2-3 mg at bedtime (1 mg for elderly/debilitated)
- For both sleep-onset and maintenance insomnia
- No short-term usage restriction
Zaleplon 1
- 10 mg at bedtime (5 mg for elderly/debilitated)
- Shortest-acting option
- Can be used for middle-of-night awakening if ≥4 hours remain for sleep
Temazepam 1
- 15-30 mg at bedtime (7.5 mg for elderly/debilitated)
- Short to intermediate-acting
Second-Line: Ramelteon (Melatonin Receptor Agonist)
- Dose: 8 mg at bedtime
- Advantage: Non-scheduled, no short-term usage restriction
- Mechanism: Melatonin receptor agonist (non-serotonergic)
- Best for: Sleep-onset insomnia 1
Important Clinical Considerations
What to Avoid
- All serotonergic agents (SSRIs, SNRIs, trazodone, mirtazapine) given your buspirone intolerance
- OTC antihistamines: Not recommended for chronic insomnia due to lack of efficacy/safety data 1
- Melatonin supplements: Insufficient evidence for chronic insomnia 1
Prescribing Pearls for BzRAs
- Take on empty stomach for maximum effectiveness
- Allow adequate sleep time (7-8 hours) to avoid residual sedation
- Avoid alcohol and other CNS depressants
- Start with lowest effective dose
- Monitor for complex sleep behaviors (sleepwalking, sleep-driving) 1
Combination Strategy
If both anxiety and insomnia are problematic:
- Use gabapentin for daytime anxiety (divided doses)
- Add a BzRA specifically for sleep at bedtime
- This approach targets different mechanisms without serotonergic overlap 1
Follow-Up Protocol
- Assess effectiveness every few weeks initially
- Monitor for side effects (sedation with gabapentin, morning grogginess with BzRAs)
- Attempt to use lowest effective maintenance doses
- Consider intermittent dosing (3 nights/week) for BzRAs once stable 1
Critical Pitfall to Avoid
Do not use benzodiazepines not specifically approved for insomnia (lorazepam, clonazepam) as primary sleep agents unless there's a specific comorbid condition warranting their use—stick to the FDA-approved sleep-specific BzRAs listed above 1.